BEONE MEDICINES LTD. (BEIGF) Net margin 2016–2025
BEONE MEDICINES LTD. (BEIGF) net profit margin by fiscal year — reported net income divided by reported revenue.
5.4%FY2025 · since FY2016: -11141.8% → 5.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 5.4% | +22.3 pp |
| FY2024 | -16.9% | +18.9 pp |
| FY2023 | -35.9% | +105.7 pp |
| FY2022 | -141.5% | -17.6 pp |
| FY2021 | -123.9% | +402.2 pp |
| FY2020 | -526.1% | -304.6 pp |
| FY2019 | -221.5% | +118.4 pp |
| FY2018 | -339.9% | -300.9 pp |
| FY2017 | -39.1% | +11102.7 pp |
| FY2016 | -11141.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Gross profitBEIGF Gross marginBEIGF Operating incomeBEIGF Operating marginBEIGF Operating cash flowBEIGF Free cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →